Selected research
Industry Research
In Vitro Skin Model Industry Research Report 2026
Market perspective
The global In Vitro Skin Model market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for In Vitro Skin Model is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for In Vitro Skin Model is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for In Vitro Skin Model is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of In Vitro Skin Model include Alcyomics, Ashland, Creative Bioarray, Episkin, Epistem, Genoskin, MatTek, Phenion(Henkel) and REPROCELL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global In Vitro Skin Model market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
In Vitro Skin Model Market by Company
Alcyomics
Ashland
Creative Bioarray
Episkin
Epistem
Genoskin
MatTek
Phenion(Henkel)
REPROCELL
Sigma-Aldrich
In Vitro Skin Model Segment by Type
Reconstructed Human Epidermis (RHE) Models
Full-Thickness or Skin Equivalent (SE) Models
Others
In Vitro Skin Model Segment by Application
Medical Testing
Cosmetic Testing
Others
In Vitro Skin Model Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Skin Model market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Skin Model and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Skin Model.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of In Vitro Skin Model manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of In Vitro Skin Model by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of In Vitro Skin Model in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Reconstructed Human Epidermis (RHE) Models
- Full-Thickness or Skin Equivalent (SE) Models
- Others
Applications
- Medical Testing
- Cosmetic Testing
- Others
Companies covered
- Alcyomics
- Ashland
- Creative Bioarray
- Episkin
- Epistem
- Genoskin
- MatTek
- Phenion(Henkel)
- REPROCELL
- Sigma-Aldrich
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global In Vitro Skin Model Market Size (2021-2032)
- 2.2.2 Global In Vitro Skin Model Sales (2021-2032)
- 2.2.3 Global In Vitro Skin Model Market Average Price (2021-2032)
- 2.3 In Vitro Skin Model by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Reconstructed Human Epidermis (RHE) Models
- 2.3.3 Full-Thickness or Skin Equivalent (SE) Models
- 2.3.4 Others
- 2.4 In Vitro Skin Model by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical Testing
- 2.4.3 Cosmetic Testing
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global In Vitro Skin Model Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global In Vitro Skin Model Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global In Vitro Skin Model Revenue of Manufacturers (2021-2026)
- 3.4 Global In Vitro Skin Model Average Price by Manufacturers (2021-2026)
- 3.5 Global In Vitro Skin Model Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of In Vitro Skin Model, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of In Vitro Skin Model, Product Type & Application
- 3.8 Global Manufacturers of In Vitro Skin Model, Established Date
- 3.9 Global In Vitro Skin Model Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alcyomics
- 4.1.1 Alcyomics Company Information
- 4.1.2 Alcyomics Business Overview
- 4.1.3 Alcyomics In Vitro Skin Model Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alcyomics In Vitro Skin Model Product Portfolio
- 4.1.5 Alcyomics Recent Developments
- 4.2 Ashland
- 4.2.1 Ashland Company Information
- 4.2.2 Ashland Business Overview
- 4.2.3 Ashland In Vitro Skin Model Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Ashland In Vitro Skin Model Product Portfolio
- 4.2.5 Ashland Recent Developments
- 4.3 Creative Bioarray
- 4.3.1 Creative Bioarray Company Information
- 4.3.2 Creative Bioarray Business Overview
- 4.3.3 Creative Bioarray In Vitro Skin Model Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Creative Bioarray In Vitro Skin Model Product Portfolio
- 4.3.5 Creative Bioarray Recent Developments
- 4.4 Episkin
- 4.4.1 Episkin Company Information
- 4.4.2 Episkin Business Overview
- 4.4.3 Episkin In Vitro Skin Model Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Episkin In Vitro Skin Model Product Portfolio
- 4.4.5 Episkin Recent Developments
- 4.5 Epistem
- 4.5.1 Epistem Company Information
- 4.5.2 Epistem Business Overview
- 4.5.3 Epistem In Vitro Skin Model Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Epistem In Vitro Skin Model Product Portfolio
- 4.5.5 Epistem Recent Developments
- 4.6 Genoskin
- 4.6.1 Genoskin Company Information
- 4.6.2 Genoskin Business Overview
- 4.6.3 Genoskin In Vitro Skin Model Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Genoskin In Vitro Skin Model Product Portfolio
- 4.6.5 Genoskin Recent Developments
- 4.7 MatTek
- 4.7.1 MatTek Company Information
- 4.7.2 MatTek Business Overview
- 4.7.3 MatTek In Vitro Skin Model Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MatTek In Vitro Skin Model Product Portfolio
- 4.7.5 MatTek Recent Developments
- 4.8 Phenion(Henkel)
- 4.8.1 Phenion(Henkel) Company Information
- 4.8.2 Phenion(Henkel) Business Overview
- 4.8.3 Phenion(Henkel) In Vitro Skin Model Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Phenion(Henkel) In Vitro Skin Model Product Portfolio
- 4.8.5 Phenion(Henkel) Recent Developments
- 4.9 REPROCELL
- 4.9.1 REPROCELL Company Information
- 4.9.2 REPROCELL Business Overview
- 4.9.3 REPROCELL In Vitro Skin Model Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 REPROCELL In Vitro Skin Model Product Portfolio
- 4.9.5 REPROCELL Recent Developments
- 4.10 Sigma-Aldrich
- 4.10.1 Sigma-Aldrich Company Information
- 4.10.2 Sigma-Aldrich Business Overview
- 4.10.3 Sigma-Aldrich In Vitro Skin Model Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sigma-Aldrich In Vitro Skin Model Product Portfolio
- 4.10.5 Sigma-Aldrich Recent Developments
5 Global In Vitro Skin Model Market Scenario by Region
- 5.1 Global In Vitro Skin Model Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global In Vitro Skin Model Sales by Region: 2021-2032
- 5.2.1 Global In Vitro Skin Model Sales by Region: 2021-2026
- 5.2.2 Global In Vitro Skin Model Sales by Region: 2027-2032
- 5.3 Global In Vitro Skin Model Revenue by Region: 2021-2032
- 5.3.1 Global In Vitro Skin Model Revenue by Region: 2021-2026
- 5.3.2 Global In Vitro Skin Model Revenue by Region: 2027-2032
- 5.4 North America In Vitro Skin Model Market Facts & Figures by Country
- 5.4.1 North America In Vitro Skin Model Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America In Vitro Skin Model Sales by Country (2021-2032)
- 5.4.3 North America In Vitro Skin Model Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe In Vitro Skin Model Market Facts & Figures by Country
- 5.5.1 Europe In Vitro Skin Model Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe In Vitro Skin Model Sales by Country (2021-2032)
- 5.5.3 Europe In Vitro Skin Model Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific In Vitro Skin Model Market Facts & Figures by Country
- 5.6.1 Asia Pacific In Vitro Skin Model Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific In Vitro Skin Model Sales by Country (2021-2032)
- 5.6.3 Asia Pacific In Vitro Skin Model Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America In Vitro Skin Model Market Facts & Figures by Country
- 5.7.1 South America In Vitro Skin Model Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America In Vitro Skin Model Sales by Country (2021-2032)
- 5.7.3 South America In Vitro Skin Model Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa In Vitro Skin Model Market Facts & Figures by Country
- 5.8.1 Middle East and Africa In Vitro Skin Model Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa In Vitro Skin Model Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa In Vitro Skin Model Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global In Vitro Skin Model Sales by Type (2021-2032)
- 6.1.1 Global In Vitro Skin Model Sales by Type (2021-2032) & (k units)
- 6.1.2 Global In Vitro Skin Model Sales Market Share by Type (2021-2032)
- 6.2 Global In Vitro Skin Model Revenue by Type (2021-2032)
- 6.2.1 Global In Vitro Skin Model Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global In Vitro Skin Model Revenue Market Share by Type (2021-2032)
- 6.3 Global In Vitro Skin Model Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global In Vitro Skin Model Sales by Application (2021-2032)
- 7.1.1 Global In Vitro Skin Model Sales by Application (2021-2032) & (k units)
- 7.1.2 Global In Vitro Skin Model Sales Market Share by Application (2021-2032)
- 7.2 Global In Vitro Skin Model Revenue by Application (2021-2032)
- 7.2.1 Global In Vitro Skin Model Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global In Vitro Skin Model Revenue Market Share by Application (2021-2032)
- 7.3 Global In Vitro Skin Model Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 In Vitro Skin Model Value Chain Analysis
- 8.1.1 In Vitro Skin Model Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 In Vitro Skin Model Production Mode & Process
- 8.2 In Vitro Skin Model Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 In Vitro Skin Model Distributors
- 8.2.3 In Vitro Skin Model Customers
9 Global In Vitro Skin Model Analyzing Market Dynamics
- 9.1 In Vitro Skin Model Industry Trends
- 9.2 In Vitro Skin Model Industry Drivers
- 9.3 In Vitro Skin Model Industry Opportunities and Challenges
- 9.4 In Vitro Skin Model Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst